X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10493) 10493
Publication (1061) 1061
Newspaper Article (266) 266
Book Review (177) 177
Book / eBook (170) 170
Newsletter (144) 144
Book Chapter (128) 128
Magazine Article (44) 44
Conference Proceeding (15) 15
Trade Publication Article (6) 6
Data Set (5) 5
Web Resource (5) 5
Dissertation (3) 3
Report (3) 3
Reference (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7863) 7863
index medicus (4824) 4824
female (4395) 4395
male (3609) 3609
animals (3401) 3401
immunology (2936) 2936
vaccines (2728) 2728
adult (2695) 2695
vaccination (2649) 2649
viruses (2158) 2158
infectious diseases (2005) 2005
antibodies, viral - blood (1953) 1953
viral vaccines - adverse effects (1785) 1785
infections (1783) 1783
middle aged (1737) 1737
immunization (1709) 1709
adolescent (1654) 1654
health aspects (1526) 1526
child (1466) 1466
research (1445) 1445
infant (1406) 1406
antibodies (1354) 1354
research article (1334) 1334
infection (1277) 1277
virology (1255) 1255
medicine, research & experimental (1247) 1247
medicine (1227) 1227
child, preschool (1199) 1199
microbiology (1182) 1182
immunogenicity (1158) 1158
viral infections (1101) 1101
viral vaccines - immunology (1077) 1077
safety (1057) 1057
mice (1050) 1050
influenza (1007) 1007
prevention (999) 999
virus diseases (968) 968
children (961) 961
antigens (938) 938
influenza vaccines - adverse effects (931) 931
multidisciplinary sciences (909) 909
proteins (903) 903
vaccine (891) 891
risk factors (871) 871
science (870) 870
immune response (864) 864
aged (852) 852
influenza vaccines - immunology (851) 851
young adult (847) 847
clinical trials (819) 819
viral vaccines - administration & dosage (790) 790
influenza, human - prevention & control (749) 749
medical research (742) 742
analysis (741) 741
viral vaccines (740) 740
veterinary sciences (724) 724
vaccines, attenuated - adverse effects (718) 718
care and treatment (710) 710
viral diseases (710) 710
virus (710) 710
studies (705) 705
immunity (691) 691
disease (689) 689
vaccination - adverse effects (672) 672
influenza vaccines - administration & dosage (657) 657
hiv (656) 656
pregnancy (656) 656
time factors (620) 620
pediatrics (611) 611
biology (607) 607
epidemiology (604) 604
public health (603) 603
vaccines, attenuated - immunology (588) 588
double-blind method (583) 583
treatment outcome (579) 579
allergy and immunology (576) 576
human immunodeficiency virus--hiv (575) 575
antibodies, viral - biosynthesis (570) 570
influenza vaccines (567) 567
viral antibodies (566) 566
cancer (564) 564
medicine, general & internal (563) 563
mortality (561) 561
antibodies, viral - immunology (545) 545
medicine and health sciences (540) 540
biology and life sciences (536) 536
hepatitis (535) 535
hemagglutination inhibition tests (534) 534
immunization schedule (519) 519
efficacy (515) 515
antibodies, viral - analysis (509) 509
viral load (499) 499
drug therapy (498) 498
immune system (484) 484
biotechnology & applied microbiology (479) 479
usage (479) 479
adults (473) 473
enzyme-linked immunosorbent assay (472) 472
antiviral agents - therapeutic use (458) 458
age (451) 451
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (129) 129
Collection Dvlpm't (Acquisitions) - Closed Orders (15) 15
UTL at Downsview - May be requested (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Online Resources - Online (9) 9
UofT at Mississauga - Stacks (7) 7
UofT at Scarborough - Stacks (7) 7
Earth Sciences (Noranda) - Stacks (3) 3
Gerstein Science - Course Reserves (2) 2
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Law (Bora Laskin) - Stacks (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10581) 10581
Russian (147) 147
German (145) 145
French (103) 103
Spanish (45) 45
Dutch (43) 43
Japanese (43) 43
Chinese (30) 30
Italian (30) 30
Swedish (19) 19
Danish (17) 17
Norwegian (11) 11
Polish (10) 10
Portuguese (8) 8
Czech (7) 7
Croatian (5) 5
Romanian (3) 3
Turkish (3) 3
Bulgarian (2) 2
Hebrew (2) 2
Hungarian (2) 2
Arabic (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, STAT!Ref electronic medical library, ISBN 9780309214360, xxvii, 865
In 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist... 
Complications | Vaccination | Vaccines | Prevention | Virus diseases | Bacterial diseases | Causality | Bacterial Infections | Virus Diseases
Book
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1156 - 1166
Summary Background Safe and effective vaccines against Ebola could prevent or control outbreaks. The safe use of replication-competent vaccines requires a... 
Infectious Disease | INFECTIOUS DISEASES | MARBURG VIRUS | ACTIVATION | DUCK RUBELLA VACCINE | IMMUNE-RESPONSES | PROTECTS NONHUMAN-PRIMATES | VESICULAR STOMATITIS | GLYCOPROTEINS | INFECTION | FEVER | AGE | Hemorrhagic Fever, Ebola - prevention & control | Vasculitis - epidemiology | Arthritis - epidemiology | Humans | Middle Aged | Vasculitis - pathology | Antigens, Viral - genetics | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Dermatitis - epidemiology | Drug Carriers | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Arthritis - chemically induced | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vesiculovirus - genetics | Adult | Ebola Vaccines - immunology | Female | Vasculitis - chemically induced | Placebos - administration & dosage | Double-Blind Method | Arthritis - pathology | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Switzerland | Drug-Related Side Effects and Adverse Reactions - epidemiology | Dermatitis - pathology | Adolescent | Aged | Vaccines, Synthetic - administration & dosage | Ebola virus | Hospitals | Clinical trials | Product development | Cross infection | Vaccines | Nosocomial infections | Health aspects | Epidemics | Disease | Arthritis | Dermatitis | Ankle | Wrist | Consortia | Pain | Adenoviruses | Fingers & toes | Skin | Public health
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2010, Volume 362, Issue 4, pp. 289 - 298
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 34, Issue 3, pp. 313 - 319
Highlights • CMV seronegative girls between 12 and 17 years of age received CMV glycoprotein B (gB) vaccine with MF59 or saline placebo at 0, 1 and 6 months. •... 
Allergy and Immunology | Cytomegalovirus | Vaccine | CMV gB | Adolescent | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | PREVENTION | TRANSPLANT RECIPIENTS | IMMUNOLOGY | ADJUVANT | PLASMA | DNA | DISEASE | CMV INFECTION | Cytomegalovirus Vaccines - adverse effects | Adjuvants, Immunologic - administration & dosage | Vaccines, Subunit - genetics | Humans | DNA, Viral - analysis | Cytomegalovirus Infections - immunology | Vaccines, Synthetic - immunology | Cytomegalovirus Vaccines - administration & dosage | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Adjuvants, Immunologic - adverse effects | Cytomegalovirus Infections - prevention & control | Vaccines, Synthetic - adverse effects | Blood - virology | Polymerase Chain Reaction | Polysorbates - administration & dosage | Female | Immunization Schedule | Vaccines, Subunit - adverse effects | Child | Cytomegalovirus Vaccines - genetics | Placebos - administration & dosage | Antigens, Viral - analysis | Polysorbates - adverse effects | Viral Envelope Proteins - genetics | Double-Blind Method | Vaccines, Synthetic - genetics | Squalene - administration & dosage | Urine - virology | Vaccines, Subunit - immunology | Squalene - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Vaccines, Subunit - administration & dosage | Viral Envelope Proteins - immunology | Vaccines, Synthetic - administration & dosage | DNA, Viral - genetics | Cytomegalovirus Vaccines - immunology | Clinical trials | Medical colleges | Vaccines | Teenage girls | Antigens | Cytomegalovirus infections | Vaccination | Urine | Confidence intervals | Substance abuse treatment | Consent | Hispanic Americans | Population | Infections | adolescent | vaccine | cytomegalovirus
Journal Article
PLoS Pathogens, ISSN 1553-7366, 2015, Volume 11, Issue 9, p. e1005142
Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a... 
ACTIVATION | RNA | PERSISTENCE | CD4(+) T-CELLS | MICROBIOLOGY | VIROLOGY | HISTONE DEACETYLASES | ACTIVE ANTIRETROVIRAL THERAPY | IMMUNODEFICIENCY-VIRUS TYPE-1 | STEM-CELL | INFECTION | PARASITOLOGY | VIRAL RESERVOIR | Follow-Up Studies | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | AIDS Vaccines - therapeutic use | Virus Latency - drug effects | AIDS Vaccines - adverse effects | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | Drug Interactions | HIV-1 - physiology | Lymphocytes - immunology | Protein Processing, Post-Translational - drug effects | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Depsipeptides - therapeutic use | RNA, Viral - metabolism | Depsipeptides - adverse effects | Biomarkers - metabolism | Lymphocytes - metabolism | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Biomarkers - blood | Histones - blood | Acetylation - drug effects | HIV-1 - immunology | Virus Activation - drug effects | Lymphocytes - drug effects | HIV Infections - drug therapy | Histones - metabolism | Infusions, Intravenous | Viral Load - drug effects | Cohort Studies | Depsipeptides - administration & dosage | HIV Infections - metabolism | Studies | Plasma | HIV | Acquired immune deficiency syndrome | Cytokines | Lymphocytes | Curing | AIDS | Infections | Human immunodeficiency virus | Research | Drug therapy
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9871, pp. 1021 - 1028
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 31, Issue 3, pp. 524 - 532
Highlights ► This Phase 1 trial evaluated the safety and immunogenicity of an RSV (F) nanoparticle vaccine. ► The vaccine was well-tolerated and no related... 
Allergy and Immunology | Respiratory syncytial virus (RSV) | Palivizumab | Fusion protein (F protein) | Competitive ELISA | SF9 insect cell | Microneutralization | Aluminum phosphate | Anti-F IgG | Nanoparticle vaccine | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | IMMUNE GLOBULIN | COTTON RATS | INFLUENZA | RISK | IMMUNOLOGY | F-GLYCOPROTEIN | INFANTS | INFECTION | YOUNG-CHILDREN | Recombinant Fusion Proteins - immunology | Single-Blind Method | Biotechnology | Respiratory Syncytial Virus Vaccines - immunology | Adjuvants, Immunologic - administration & dosage | Aluminum Compounds - adverse effects | Phosphates - administration & dosage | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Male | Nanoparticles - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Adjuvants, Immunologic - adverse effects | Young Adult | Respiratory Syncytial Virus Vaccines - adverse effects | Sf9 Cells | Technology, Pharmaceutical | Vaccines, Virosome - immunology | Vaccines, Synthetic - adverse effects | Placebos - adverse effects | Adult | Female | Placebos - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Vaccines, Virosome - administration & dosage | Vaccines, Synthetic - genetics | Vaccines, Virosome - genetics | Animals | Aluminum Compounds - administration & dosage | Phosphates - adverse effects | Vaccines, Virosome - adverse effects | Respiratory Syncytial Virus Vaccines - administration & dosage | Adolescent | Recombinant Fusion Proteins - genetics | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Respiratory Syncytial Virus Vaccines - genetics | Antibodies, Neutralizing - blood | Virus diseases | Phosphates | Vaccines | Immunoglobulin G | Enzyme-linked immunosorbent assay | Proteins | Nanoparticles | Infections | Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1610 - 1623
Journal Article